Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals

Aerie Pharmaceuticals Price Chart AERI

Historical daily share price chart and data for Aerie Pharmaceuticals since 2013 adjusted for splits and dividends. The latest closing price for Aerie Pharmaceuticals as of September 18, 2020 is $12.2.
  • In 2020 the stock opened at $24.56 and closed at $12.20 for a loss of -101% YTD.
  • In 2019 the stock opened at $35.34 and closed at $24.17 for a loss of -46%.
  • In 2018 the stock opened at $59.75 and closed at $36.10 for a loss of -66%.
  • In 2017 the stock opened at $39.00 and closed at $59.75 for a gain of 35%.
View Chart On Koyfin

Aerie Pharmaceuticals Summary

Stock Symbol: AERI

Aerie Pharmaceuticals Company Info

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, dry eye, retinal diseases, and other eye diseases. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma and ocular hypertension. The company is also developing AVX-012, a clinical-stage dry eye product candidate; and AR-1105 and AR-13503 sustained-release implants for treating retinal diseases. Aerie Pharmaceuticals, Inc. has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.
Market Cap
567.5m
Dividend Yield
0 %
Beta vs SPX
1.09
Short Interest
836.21 %
30D Volatility
56.24
Hedge Fund Held
0 %
Competitors

Last 10 Days of AERI Prices

09/18/2020$12.20
09/17/2020$11.79
09/16/2020$11.69
09/15/2020$11.55
09/14/2020$11.12
09/11/2020$10.46
09/10/2020$10.83
09/09/2020$11.62
09/08/2020$11.95
09/04/2020$11.67